Ploretin derivative and preparation method and application thereof
By introducing amide structure into rhizolin and forming flavanone, the problem of insufficient application of rhizolin derivatives in the field of pesticides was solved, and a high herbicidal activity of rhizolin derivatives were obtained, which achieved heterogeneous dicotyledon and monocotyledon leaves Effective inhibition of grass.
Patent Information
- Application Number
- CN202411048988.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-19
AI Technical Summary
In the prior art, rhizocarcin and its derivatives are less used in the field of pesticides, and flavanone compounds have low content in natural products and are difficult to extract, resulting in less research on them.
By introducing the amide structure into the rhizolin molecule, a rhizolin derivative containing an amide structure is synthesized, and double bonds are introduced into the carbon chain of the rhizolin parent structure to form flavanone, thereby obtaining rhizolin derivatives with high herbicidal activity. Things.
The successful synthesis of root urinary dermatin derivatives with high herbicidal activity can effectively inhibit the growth of dicotyledon and monocotyledon weeds, providing a new herbicide and plant growth regulator.
Smart Images

Figure CN118978453A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to agricultural herbicides, in particular to natural product phloretin derivatives and preparation methods thereof and applications thereof in weed control. Background Art
[0002] The natural product phloretin and its derivatives have a wide range of biological activities such as bactericidal, anti-inflammatory, anti-oxidant, anti-tumor, hypoglycemic, and tyrosinase inhibition, and phloretin is safe and non-toxic to the human body, and has great application prospects in the fields of food, medicine, and cosmetics. The inventor consulted relevant information and learned that phloretin is rarely reported in the field of pesticides. Therefore, it is of great significance to carry out structural derivation of phloretin and study its derivatives with agricultural application value.
[0003] Amide structures are active structures widely present in various drug compounds, with biological properties such as bactericidal, herbicidal, and insecticidal. Complex molecules containing benzamide structures have always been a research hotspot in organic chemistry and medicinal chemistry. If the benzamide structure can be introduced into the phloretin molecule efficiently and conveniently to obtain a class of active phloretin derivatives, it will have positive significance both in the field of pharmaceutical science and organic methodology.
[0004] Flavanones and their derivatives contain a C6-C3-C6 skeleton structure of the C ring and are important biologically active natural products with antioxidant, anti-cancer, anti-inflammatory, bactericidal, and anti-HIV activities. However, due to the low content of flavanone compounds in natural products and the difficulty in extraction, there is less research on them in the academic community compared to other flavonoids. Therefore, it is very meaningful to study the synthesis and activity of this type of compound. Summary of the invention
[0005] The purpose of the present invention is to provide a series of novel phloretin derivatives with herbicidal activity. By taking the natural product phloretin as a lead compound, retaining its biologically active structure, and introducing an amide group into the phloretin parent structure by utilizing the active splicing principle, the phloretin derivatives containing an amide structure are successfully synthesized, and double bonds are introduced into the carbon chain of the phloretin parent structure and a cyclization is performed at the double bonds of the carbon chain to form flavanones, and flavanone-type phloretin derivatives are successfully synthesized, thereby obtaining a series of phloretin derivatives with high herbicidal activity.
[0006] The objective of the present invention is achieved through the following technical solutions:
[0007] Phloretin derivatives or physiologically compatible salts thereof having structures as shown in Formula I and Formula II:
[0008]
[0009] wherein R1 is selected from H, F, Cl, Br, C1-C3 alkyl, OH, C1-C3 alkoxy or halogen-substituted C1-C3 alkyl, but does not include R1 selected from Cl substituted at the 4' position;
[0010] R2 is selected from F, Cl, Br, C1-C3 alkyl, C1-C3 alkoxy, halogen-substituted C1-C3 alkyl, but does not include R2 selected from OCH3, Cl, Br substituted at the 2' position, CH3, OCH3, Cl, Br substituted at the 3' position, and CH3, OCH3, CF3, F, Cl, Br substituted at the 4' position.
[0011] Preferably, R1 is selected from H, F, Cl, Br, CH3, OH, OCH3 or CF3, but does not include OH substituted at the 2' position and Cl substituted at the 4' position; R2 is selected from F, CH3 or CF3 substituted at the 2' position and F or CF3 substituted at the 3' position.
[0012] Further preferably, R1 is selected from H, F, Cl, Br, CH3, OCH3 or CF3 substituted at the 2' position, F, Cl, Br, CH3, OCH3 or CF3 substituted at the 3' position, and F, CH3, OCH3 or CF3 substituted at the 4' position; R2 is selected from F or CF3 substituted at the 2' position, and F or CF3 substituted at the 3' position.
[0013] More preferably, R1 is selected from H, F, Cl or OCH3 substituted at the 2' position, Cl, CH3, OCH3 or CF3 substituted at the 3' position, and F or CH3 substituted at the 4' position.
[0014] Most preferably, R1 is selected from Cl substituted at the 2' position, CH3 or OCH3 substituted at the 3' position, and F substituted at the 4' position.
[0015] The phloretin derivative with the structure shown in formula I is a phloretin derivative containing an amide structure; the phloretin derivative with the structure shown in formula II is a flavanone phloretin derivative or a physiologically compatible salt thereof.
[0016] Specifically, the phloretin derivative containing an amide structure or a physiologically compatible salt thereof is as follows:
[0017]
[0018]
[0019] Specifically, the flavanone phloretin derivative or its physiologically compatible salt has the following structure:
[0020]
[0021] Another object of the present invention is to provide a method for preparing the phloretin derivative.
[0022] The synthetic route of phloretin derivatives containing amide structure is as follows:
[0023]
[0024] Wherein, R1 is as described above.
[0025] The method comprises: under nitrogen protection, using a mixed solvent of 1,4-dioxane and water as a reaction solvent, using N,N'-dicyclohexylcarbodiimide (DCC) and N-hydroxysuccinimide (NHS) as condensation agents, and in the presence of sodium bicarbonate, reacting 2,4,6-trihydroxybenzoic acid with substituted or unsubstituted benzylamine to obtain a phloretin derivative containing an amide structure as shown in formula I.
[0026] The volume ratio of 1,4-dioxane to water is 2:1.
[0027] To ensure that 2,4,6-trihydroxybenzoic acid is completely reacted, substituted or unsubstituted benzylamine is used in excess. Generally, the molar ratio of 2,4,6-trihydroxybenzoic acid to substituted or unsubstituted benzylamine is 1:1 to 1:1.5, preferably 1:1.1.
[0028] The molar ratio of the 2,4,6-trihydroxybenzoic acid to N-hydroxysuccinimide is 0.8:1-1.5:1, preferably 1:1; the molar ratio of the 2,4,6-trihydroxybenzoic acid to N,N'-dicyclohexylcarbodiimide is 0.8:1-1.5:1, preferably 1:1.
[0029] The molar ratio of the 2,4,6-trihydroxybenzoic acid to sodium bicarbonate is 0.8:1 to 1.5:1, preferably 1:1.
[0030] The reaction temperature is 40-80°C.
[0031] The synthetic route of flavanone phloretin derivatives is as follows:
[0032]
[0033] Wherein, R2 is as described above.
[0034] The method comprises: using 95% ethanol as a reaction solvent, under alkaline conditions, 4,6-dimethoxy-2-hydroxyacetophenone and substituted or unsubstituted benzaldehyde are subjected to a Claisen-Schmidt condensation reaction to synthesize a chalcone phloretin derivative shown in formula VII; during the reaction, acetophenone is activated by deprotonation in an alkaline medium, and then the formed acetophenone anion attacks the carbonyl group of benzaldehyde to generate a chalcone phloretin derivative; using 95% ethanol as a reaction solvent, under the condition of the presence of sodium acetate, the chalcone phloretin derivative undergoes a cyclization reaction to obtain a flavanone phloretin derivative shown in formula II; during the reaction, the chalcone phloretin derivative forms an oxygen anion under alkaline conditions, and then attacks the carbon atom at the unsaturated β position thereof for addition cyclization.
[0035] In order to ensure that the substituted benzaldehyde is completely reacted, 4,6-dimethoxy-2-hydroxyacetophenone is used in excess. Generally, the molar ratio of 4,6-dimethoxy-2-hydroxyacetophenone to the substituted or unsubstituted benzaldehyde is 1.5:1 to 2:1, preferably 1.8:1.
[0036] The alkaline condition is provided by sodium hydroxide. The molar ratio of 4,6-dimethoxy-2-hydroxyacetophenone to sodium hydroxide is 1.5:10 to 2:10, preferably 1.8:10.
[0037] The temperature of the Claisen-Schmidt condensation reaction is room temperature.
[0038] In order to ensure the complete reaction of the chalcone phloretin derivative, the sodium acetate is excessive. Generally, the molar ratio of the chalcone phloretin derivative to sodium acetate is 1:8 to 1:12, preferably 1:10.
[0039] The cyclization reaction is carried out under heating reflux conditions.
[0040] The preparation method of the phloretin derivatives and flavanone phloretin derivatives containing an amide structure described in the present invention also includes the purification of the target compound. There are no special requirements for the purification method, and various purification methods conventionally used by technicians in this field can be used. For example, extraction with an extractant, drying with a desiccant, and impurities can be removed by methods such as column chromatography.
[0041] The amide-containing phloretin derivatives and flavanone phloretin derivatives of the present invention both exhibit high-efficiency and / or broad-spectrum herbicidal activity. Therefore, another object of the present invention is to provide the use of the phloretin derivatives or physiologically compatible salts thereof in plant growth regulation.
[0042] The plant growth regulation is to inhibit the root length and plant height of the plant.
[0043] Another object of the present invention is to provide the use of the phloretin derivative or its physiologically compatible salt in weed control.
[0044] Preferably, the application is the application of the phloretin derivative or its physiologically compatible salts in controlling dicotyledonous weeds and monocotyledonous weeds.
[0045] More preferably, the application is the application of the phloretin derivative or its physiologically compatible salts in controlling dicotyledonous weeds.
[0046] The dicotyledonous weeds are purslane, amaranth, water peanut, spiny amaranth, mallow, ramie, sorrel leaf polygonum, sheep's foot, kangbangui, water polygonum, tooth fruit sorrel, iron amaranth, humulus, perilla, weasel flower, baicao, shepherd's purse, veronica, Persian veronica, dayflower, matchhead, cup flower, horse hoof tendon, morning glory, rice cha vegetable, Xanthium, small flying horn, chrysanthemum intestine, sorrel, amaranth, yellow quail vegetable, chrysanthemum, prickly lettuce, annual hornwort, ragweed , Tianmingjing, purple stem ageratum, clover, snakeberry, blackberry, creeper, quinoa, Oxalis, plantain, duckweed, zelkova, chickweed, chickweed, bottle grass, indigo, Artemisia, shepherd's purse, indigo, cardamine, cleaver, and wheat kernel pearl; the monocotyledonous weeds are barnyard grass, crabgrass, goosegrass, Leptochloa, Setaria, big foxtail, bluegrass, wild oats, alopecuroides, Japanese alopecuroides, weed grass, hard grass, and stick grass.
[0047] Another object of the present invention is to provide a plant growth regulator or herbicide, which contains the phloretin derivative or its physiologically compatible salt as an effective ingredient or main effective ingredient.
[0048] Application of phloretin derivatives with structures shown in Formula I and Formula II or their physiologically compatible salts in weed control:
[0049]
[0050] Among them, R1 is selected from Cl substituted at the 4' position; R2 is selected from OCH3, Cl, Br substituted at the 2' position, CH3, OCH3, Cl, Br substituted at the 3' position, and CH3, OCH3, CF3, F, Cl, Br substituted at the 4' position.
[0051] Preferably, R1 is selected from Cl substituted at the 4' position; R2 is selected from OCH3, Cl substituted at the 2' position, CH3, OCH3, Br substituted at the 3' position, and OCH3, F, Cl substituted at the 4' position.
[0052] Preferably, the application is the application of the phloretin derivative or its physiologically compatible salts in controlling dicotyledonous weeds and monocotyledonous weeds.
[0053] Specifically, the phloretin derivatives or physiologically compatible salts thereof with the following structures are used in plant growth regulation or weed control:
[0054]
[0055] Compared with the prior art, the present invention has the following beneficial effects:
[0056] 1. The present invention uses 2,4,6-trihydroxybenzoic acid and unsubstituted or various substituted benzylamines as starting materials, and a phloretin derivative containing an amide structure can be obtained through a simple one-step reaction.
[0057] 2. The present invention uses 4',6-dimethyl-2-hydroxyacetophenone and unsubstituted or substituted benzaldehyde as starting materials to obtain flavanone phloretin derivatives through a simple three-step reaction.
[0058] 3. The phloretin derivatives and flavanone phloretin derivatives of the present invention have good herbicidal activity and can be used as herbicides in crop production. BRIEF DESCRIPTION OF THE DRAWINGS
[0059] Figure 1 The inhibitory effects of compounds A1, A5 and A7 on Portulaca oleracea.
[0060] Figure 2 This is the inhibitory effect of compounds C3 and C4 on Portulaca oleracea. DETAILED DESCRIPTION
[0061] The technical solution of the present invention will be described in detail below through embodiments.
[0062] In the following examples, unless otherwise specified, all raw materials used were purchased from commercial sources and were of analytical purity. The room temperature was 25°C.
[0063] Example 1
[0064] The 2,4,6-trihydroxybenzoic acid shown in Formula III and the substituted or unsubstituted benzylamine shown in Formula IV are used as raw materials to synthesize the phloretin derivative containing an amide structure shown in Formula I. The synthesis route is as follows:
[0065]
[0066] The specific steps are as follows:
[0067] Dissolve 2,4,6-trihydroxybenzoic acid (1mmol), N-hydroxysuccinimide (1mmol) and N,N'-dicyclohexylcarbodiimide (1mmol) in 1,4-dioxane (2.0mL), stir at 20-25°C for 16 hours under nitrogen protection; filter to remove the precipitate, add the filtrate directly to a mixed aqueous solution (1mL) of substituted or unsubstituted benzylamine (1.1mmol) and sodium bicarbonate (1mmol), heat to 50°C under nitrogen protection, maintain 50°C stirring reaction for 1 hour; after the reaction, cool the reaction solution to room temperature, add 18mL of dilute hydrochloric acid (10%), extract with ethyl acetate, combine the organic phases, wash the organic phases with saturated brine, add anhydrous Na2SO4 to dry, use silica gel column chromatography, use PE / EA with a volume ratio of 5:1 to 10:1 as eluent, purify to obtain the target compound, dry, and weigh. Calculate the yield, use 1 H NMR, 13 Its structure was characterized by C NMR, IR and HRMS.
[0068] The phloretin derivatives containing amide structure are shown in Table 1.
[0069]
[0070] Table 1. Phloretin derivatives containing amide structure
[0071] Compound No. <![CDATA[R1]]> Compound No. <![CDATA[R1]]> A1 H A12 3'-OH A2 <![CDATA[2’-CH3]]> A13 3’-F A3 <![CDATA[2’-OCH3]]> A14 3’-Cl A4 <![CDATA[2’-CF3]]> A15 3’-Br A5 2'-OH A16 <![CDATA[4’-CH3]]> A6 2’-F A17 <![CDATA[4’-OCH3]]> A7 2’-Cl A18 <![CDATA[4’-CF3 <!-- 6 -->]]> A8 2’-Br A19 4'-OH A9 <![CDATA[3’-CH3]]> A20 4’-F A10 <![CDATA[3’-OCH3]]> A21 4’-Cl A11 <![CDATA[3’-CF3]]> A22 4’-Br
[0072] The spectral data of the target compound are as follows:
[0073] A1: N-Benzyl-2,4,6-trihydroxybenzamide
[0074]
[0075] Brown solid; yield: 30%. mp 208.2-209.8℃. 1 H NMR (500MHz, DMSO-d6) δ12.57 (s, 1H), 9.94 (s, 1H), 9.04 (t, J = 5.5Hz, 1H), 7.33 (dd, J=10.5,4.0Hz,2H),7.28-7.24(m,1H),5.82(d,J=2.0Hz,1H),4.52(d,J=6.0Hz,1H). 13 C NMR(125MHz,DMSO-d6)δ170.31,162.10,161.95,139.34,128.61,127.40,127.09,95.38,94.90,42.26.HRMS(MALDI):m / z calcdfor C14 H 13 NO4([M+H] + )260.0917,Found 260.0920.
[0076] A2: N-(2'-methylbenzyl)-2,4,6-trihydroxybenzamide
[0077]
[0078] Yellow solid; yield: 48%. mp131.8-133.1℃. 1 H NMR(500MHz,DMSO-d6)δ12.59(s,1H),9.95(s,1H),8.93(t,J=5.0Hz,1H),7.25-7.22(m, 1H),7.20-7.16(m,2H),5.85-5.81(m,1H),4.50(d,J=5.5Hz,1H),2.32(d,J=14.0Hz,2H). 13 C NMR (125MHz, DMSO-d6) δ170.19,162.08,161.90,136.84,135.64,130.24,127.38,127.19,126.09,95.37,94.93,40.41,18.75.HRMS(MALDI):m / z calcd for C 15 H 15 NO4([M+H] + )274.1074,Found 274.1067.
[0079] A3: N-(2'-methoxybenzyl)-2,4,6-trihydroxybenzamide
[0080]
[0081] Pale yellow solid; yield: 40%. mp201.9-203.5℃. 1 H NMR (500MHz, DMSO-d6) δ12.83-12.35(m,1H),9.91(s,1H),9.06(t,J=5.5Hz,1H),7.33-7.15(m,1H),7.02(d ,J=8.0Hz,1H),6.91(t,J=7.5Hz,1H),5.82(d,J=14.5Hz,1H),4.46(d,J=6.0Hz,1H),3.86(d,J=14.5Hz,2H). 13C NMR (125MHz, DMSO-d6) δ170.09,162.05,157.18,128.73,128.44,126.43,120.49,110.86,95.44,94.92,55.55,38.16.HRMS(MALDI):m / z calcd for C 15 H 15 NO5([M+H] + )290.1023,Found 290.1022.
[0082] A4: N-(2'-trifluoromethylbenzyl)-2,4,6-trihydroxybenzamide
[0083]
[0084] Brown solid; yield: 29%. mp 138.7-139.2°C. 1H NMR (500 MHz, DMSO-d6) δ 12.52 (s, 1H), 9.99 (s, 1H), 9.15 (t, J = 5.5 Hz, 1H), 7.73 (t, J = 10.5 Hz, 1H), 7.72-7.58 (m, 1H), 7.57-7.45 (m, 2H), 5.84 (s, 1H), 4.71 (d, J = 5.3 Hz, 1H). 13 C NMR(125MHz,DMSO-d6)δ170.44,162.29,162.00,137.49,132.99,128.92,127.65,126.88-125.59(m),95.23,94.90,41.88.HRMS(MALDI):m / z calcd for C 15 H 12 F3NO4([M+H] + )328.0791,Found 328.0793.
[0085] A5: N-(2'-Hydroxybenzyl)-2,4,6-trihydroxybenzamide
[0086]
[0087] Brown solid; yield: 46%. mp219.1-220.5℃. 1H NMR (500MHz, DMSO-d6) δ12.60(s,1H),9.92(s,1H),9.67(s,1H),9.02(t,J=6.0Hz,1H),7.15(dd,J=7.5,1.0Hz,1H),7.1 0(tt,J=11.0,5.5Hz,1H),6.84(dt,J=6.5,3.0Hz,1H),6.76(td,J=7.5,1.0Hz,1H),5.81(s,1H),4.43(d,J=6.0Hz,1H). 13 C NMR(125MHz,DMSO-d6)δ170.09,162.05,157.18,128.73,128.44,126.43,120.49,110.86,95.44,94.92,55.55,38.16.HRMS(MALDI):m / zcalcd for C 14 H 13 NO5([M+H] + )276.0866,Found 276.0868.
[0088] A6: N-(2'-Fluorobenzyl)-2,4,6-trihydroxybenzamide
[0089]
[0090] Yellow solid; yield: 25%. mp131.1-132.3℃. 1 H NMR (500MHz, DMSO-d6) δ12.55(s,1H),9.97(s,1H),9.06(t,J=6.0Hz,1H),7.37-7.30(m,1H),7.23-7.16(m,1H),5.82(s,1H),4.56(d,J=6.0Hz,1H). 13 C NMR (125MHz, DMSO-d6) δ170.30,162.18,161.92,137.28129.35(d,J=32.7Hz),124.62,115.32(d,J=21.1Hz),94.90,94.55,41.86HRMS(MALDI):m / z calcd for C 14 H 12 FNO4([M+H] + )278.0823,Found 278.0825.
[0091] A7: N-(2'-chlorobenzyl)-2,4,6-trihydroxybenzamide
[0092]
[0093] Gray solid; yield: 56%. mp192.3-193.8℃. 1 H NMR (500MHz, DMSO-d6) δ12.52(s,1H),9.94(s,1H),9.12(t,J=6.0Hz,1H),7.49-7.43(m,1H),7.41-7.24(m,2H),5.83(s,1H),4.58(d,J=6.0Hz,1H). 13 C NMR (125MHz, DMSO-d6) δ170.35,162.16,161.89,136.23,132.23,129.32,129.06,128.88,127.39,95.26,94.87,40.36.HRMS(MALDI):m / z calcdforC 14 H 12 ClNO4([M+H] + )294.0528,Found 294.0524.
[0094] A8: N-(2'-bromobenzyl)-2,4,6-trihydroxybenzamide
[0095]
[0096] Gray solid; yield: 22%. mp123.8-125.4℃. 1 H NMR (500MHz, DMSO-d6) δ12.52(s,1H),9.95(s,1H),9.13(t,J=6.0Hz,1H),7.63(d,J=8.0H z,1H),7.36(dt,J=7.5,7.0Hz,1H),7.26-7.21(m,1H),5.82(s,1H),4.54(d,J=6.0Hz,1H). 13 C NMR(125MHz,DMSO-d6)δ170.32,162.16,161.89,137.75,132.55,129.17,129.12,127.95,122.55,95.23,94.85,42.79.HRMS(MALDI):m / z calcd forC 14 H 12 BrNO4([M+H] + )338.0022,Found 338.0020.
[0097] A9: N-(3'-methylbenzyl)-2,4,6-trihydroxybenzamide
[0098]
[0099] Pale yellow solid; yield: 24%. mp128.4-129.3℃. 1 H NMR(500MHz,DMSO-d6)δ12.57(s,1H),9.92(s,1H),9.01(t,J=6.0Hz,1H),7.26-7.18( m,1H),7.11(dt,J=20.0,11.0Hz,2H),5.82(s,1H),4.48(d,J=6.0Hz,1H),2.29(s,2H). 13 C NMR (125MHz, DMSO-d6) δ170.18,162.02,161.86,139.14,137.64,128.46,127.94,127.69,124.45,95.36,94.87,42.17,21.12.HRMS(MALDI):m / z calcd forC 15 H 15 NO4([M+H] + )274.1074,Found 274.1072.
[0100] A10: N-(3'-methoxybenzyl)-2,4,6-trihydroxybenzamide
[0101]
[0102] Pale yellow solid; yield: 21%. mp135.4-138.1℃. 1 H NMR (500MHz, DMSO-d6) δ12.58(s,1H),9.96(s,1H),9.03(t,J=6.0Hz,1H),7.25(t,J=8.0Hz,1H),6 .89(d,J=7.0Hz,1H),6.83(dd,J=8.0,1.5Hz,1H),5.82(s,1H),4.49(d,J=6.0Hz,1H),3.74(s,2H). 13 C NMR (125MHz, DMSO-d6) δ170.18,162.02,161.86,139.14,137.64,128.46,127.94,127.69,124.45,95.36,94.87,42.17,21.12.HRMS(MALDI):m / z calcd for C 15 H15 NO5([M+H] + )290.1023,Found 290.1027.
[0103] A11: N-(3'-trifluoromethylbenzyl)-2,4,6-trihydroxybenzamide
[0104]
[0105] White solid; yield: 44%. mp198.2-199.6℃. 1 H NMR (500MHz, DMSO-d6) δ12.60(s,1H),10.06(s,1H),9.18(t,J=6.0Hz,1H),7.75-7.47(m,2H),5.88(s,1H),4.60(d,J=6.0Hz,1H). 13 C NMR(125MHz,DMSO-d6)δ170.50,162.24,161.96,141.14,131.56,129.58,129.09,125 .50,124.10-123.79(m),123.71(d,J=4.2Hz),95.25,94.91,41.87.HRMS(MALDI):m / z calcd for C 15 H 12 F3NO4([M+H] + )328.0791,Found 328.0787.
[0106] A12: N-(3'-Hydroxybenzyl)-2,4,6-trihydroxybenzamide
[0107]
[0108] Pale yellow solid; yield: 30%. mp237.3-238.6℃. 1 H NMR (500MHz, DMSO-d6) δ12.59(s,1H),9.94(s,1H),9.37(s,1H),8.99(t,J=5.9Hz,1H),7.12(t, J=7.8Hz,1H),6.72(d,J=7.3Hz,1H),6.64(d,J=8.8Hz,1H),5.82(s,1H),4.43(d,J=5.9Hz,1H). 13C NMR (125MHz, DMSO-d6) δ170.28,162.10,161.97,157.66,140.74,129.62,117.93,114.05(d,J=2.0Hz),95.39,94.92,42.14.HRMS(MALDI):m / z calcd for C 14 H 13 NO5([M+H] + )276.0866,Found276.0864.
[0109] A13: N-(3'-fluorobenzyl)-2,4,6-trihydroxybenzamide
[0110]
[0111] White solid; yield: 28%. mp134.6-135.8℃. 1 H NMR(500MHz,DMSO-d6)δ12.52(s,1H),9.94(s,1H),9.09(t,J=6.0Hz,1H),7 .38(q,J=8.0Hz,1H),7.21-7.01(m,2H),5.83(s,1H),4.53(d,J=6.0Hz,1H). 13 C NMR (125MHz, DMSO-d6) δ170.37,163.34,162.14,161.93,161.41,142.52,142.46,130.48(d,J=8 .3Hz),123.32(d,J=2.9Hz),113.88(dd,J=34.5,21.2Hz),95.30,94.86,41.79.HRMS(MALDI):m / z calcd for C 14 H 12 FNO4([M+H] + )278.0823,Found 278.0826.
[0112] A14: N-(3'-chlorobenzyl)-2,4,6-trihydroxybenzamide
[0113]
[0114] Brown solid; yield: 27%. mp128.7-129.8℃. 1H NMR(500MHz,DMSO-d6)δ12.52(s,1H),9.96(d,J=21.5Hz,1H),9.11(t,J=5.5Hz,1H), 7.43-7.34(m,1H),7.30(dd,J=11.5,8.0Hz,1H),5.84(s,1H),4.52(d,J=6.0Hz,1H). 13 C NMR (125MHz, DMSO-d6) δ170.38,162.17,161.94,142.13,133.17,130.39,127.16,126.93,126.05,95.31,94.89,41.74.HRMS(MALDI):m / z calcd forC 14 H 12 ClNO4([M+H] + )294.0528,Found 294.0526.
[0115] A15: N-(3'-bromobenzyl)-2,4,6-trihydroxybenzamide
[0116]
[0117] Pale yellow solid; yield: 38%. mp132.9-134.4℃. 1 H NMR(500MHz,DMSO-d6)δ12.56(d,J=31.5Hz,1H),9.96(s,1H),9.11(t,J=6.0Hz,1H),7. 51(s,1H),7.44(t,J=9.5Hz,1H),7.36-7.27(m,1H),5.82(s,1H),4.51(d,J=6.0Hz,1H). 13 C NMR(125MHz,DMSO-d6)δ170.39,162.19,161.96,142.44,130.73,130.08,129.85,126.48,121.82,95.31,94.90,41.72.HRMS(MALDI):m / z calcd forC 14 H 12 BrNO4([M+H] + )338.0022,Found 338.0026.
[0118] A16: N-(4'-methylbenzyl)-2,4,6-trihydroxybenzamide
[0119]
[0120] Pale yellow solid; yield: 26%. mp183.2-184.4℃. 1 H NMR(500MHz,DMSO-d6)δ12.60(s,1H),9.95(s,1H),9.00(t,J=6.0Hz,1H),7.21(d,J =8.0Hz,1H),7.14(d,J=8.0Hz,1H),5.83(s,1H),4.47(d,J=6.0Hz,1H),2.28(s,2H). 13 C NMR (125MHz, DMSO-d6) δ170.56, 162.40, 162.26, 136.55 (d, J = 1.4Hz), 129.50, 127.78, 95.75, 95.26, 42.37, 21.18 (d, J = 1.2Hz). HRMS (MALDI): m / z calcd forC 15 H 15 NO4([M+H] + )274.1074,Found 274.1071.
[0121] A17: N-(4'-methoxybenzyl)-2,4,6-trihydroxybenzamide
[0122]
[0123] Pale yellow solid; yield: 23%. mp202.6-203.5℃. 1 H NMR (500MHz, DMSO-d6) δ12.54(s,1H),9.89(s,1H),8.94(t,J=6.0Hz,1H),7.25(d,J= 8.56Hz,1H),6.90(d,J=8.5Hz,1H),5.80(s,1H),4.43(d,J=6.0Hz,1H),3.73(s,2H). 13 C NMR(125MHz,DMSO-d6)δ170.07,161.95,161.82,158.43,131.08,128.80,113.94,95.34,94.83,55.13,41.66.HRMS(MALDI):m / z calcd for C 15 H 15 NO5([M+H] + )290.1023,Found 290.1020.
[0124] A18: N-(4'-trifluoromethylbenzyl)-2,4,6-trihydroxybenzamide
[0125]
[0126] Pale yellow solid; yield: 20%. mp 122.6-123.3°C. 1H NMR (500 MHz, DMSO-d6) δ 12.51 (d, J = 20.0 Hz, 1H), 9.96 (s, 1H), 9.17 (t, J = 6.0 Hz, 1H), 7.70 (d, J = 8.0 Hz, 1H), 7.52 (d, J = 8.0 Hz, 1H), 5.82 (s, 1H), 4.60 (d, J = 6.0 Hz, 1H). 13 C NMR (125MHz, DMSO-d6) δ170.48, 162.18, 161.96, 144.46 (d, J = 1.6Hz), 127.92, 125.38 (q, J = 4.1Hz), 123.40, 95.27, 94.85, 41.93. HRMS (MALDI): m / z calcd for C 15 H 12 F3NO4([M+H] + )328.0791,Found328.0794.
[0127] A19: N-(4'-Hydroxybenzyl)-2,4,6-trihydroxybenzamide
[0128]
[0129] Pale yellow solid; yield: 25%. mp231.5-232.3℃. 1 H NMR(500MHz,DMSO-d6)δ12.58(s,1H),9.92(s,1H),9.33(s,1H),8.90(t,J=5.5Hz,1H ),7.15(t,J=13.5Hz,1H),6.72(d,J=8.5Hz,1H),5.80(s,1H),4.38(d,J=5.5Hz,1H). 13 C NMR(125MHz,DMSO-d6)δ170.03,161.96,161.86,156.55,129.28,128.88,115.32,95.36,94.86,41.80.HRMS(MALDI):m / zcalcd for C 14 H 13 NO5([M+H] + )276.0866,Found 276.0863.
[0130] A20: N-(4'-Fluorobenzyl)-2,4,6-trihydroxybenzamide
[0131]
[0132] Pale yellow solid; yield: 29%. mp158.1-159.4℃. 1 H NMR(500MHz,DMSO-d6)δ12.54(s,1H),9.93(s,1H),9.05(t,J=5.5Hz,1H),7.42-7 .32(m,1H),7.16(td,J=9.0,1.5Hz,1H),5.86-5.79(m,1H),4.50(d,J=5.5Hz,1H). 13 C NMR (125MHz, DMSO-d6) δ170.27, 162.30, 162.08, 161.90 (d, J = 1.4Hz), 135.58 (d, J = 3 .1Hz),129.42(d,J=8.2Hz),115.33,115.16,95.32,94.85,41.52.HRMS(MALDI):m / z calcd for C 14 H 12 FNO4([M+H] + )278.0823,Found 278.0824.
[0133] A21: N-(4'-chlorobenzyl)-2,4,6-trihydroxybenzamide
[0134]
[0135] Pale yellow solid; yield: 41%. mp213.1-214.0℃. 1 H NMR(500MHz,DMSO-d6)δ12.54(s,1H),9.95(s,1H),9.08(t,J=5.5Hz,1H),7.3 9(d,J=8.0Hz,1H),7.34(d,J=8.0Hz,1H),5.81(s,1H),4.50(d,J=6.0Hz,1H). 13 C NMR(125MHz,DMSO-d6)δ170.42,162.19,162.00,138.57,131.62,129.31,128.54,95.37,94.93,41.66.HRMS(ESI):m / z calcd forC 14 H 12 ClNO4([M+H] +)294.0528,Found 294.0528.
[0136] A22: N-(4'-bromobenzyl)-2,4,6-trihydroxybenzamide
[0137]
[0138] Pale yellow solid; yield: 59%. mp218.3-219.4℃. 1 H NMR(500MHz,DMSO-d6)δ12.54(s,1H),9.95(s,1H),9.08(t,J=6.0Hz,1H),7.5 3(d,J=8.5Hz,1H),7.27(t,J=7.5Hz,1H),5.81(s,1H),4.48(d,J=6.0Hz,1H). 13 C NMR(125MHz,DMSO-d6)δ170.37,162.14,161.94,138.97,131.39,129.62,120.01,95.31,94.87,41.67.HRMS(ESI):m / z calcd forC 14 H 12 BrNO4([M+H] + )338.0022,Found 338.0026.
[0139] Example 2
[0140] Evaluation of the herbicidal activity of phloretin derivatives containing amide structure
[0141] Seed germination experiments were conducted on the target compounds, with dicotyledonous plants (Purslane) and monocotyledonous plants (Echinochloa crusgalli) as experimental subjects.
[0142] Experimental equipment: high pressure sterilizer, pipette, electric constant temperature biochemical incubator, double-sided clean workbench for two people, 5mm puncher, inoculation ring, alcohol lamp, culture dish, etc.
[0143] Experimental material preparation: The target compound was dissolved in DMSO to prepare a mother solution with a concentration of 50000 μg / mL. Agar (Merck, USA) was weighed on a balance and dissolved in double distilled water to prepare an agar medium with a mass fraction of about 2.0% and sterilized under high temperature and high pressure.
[0144] Experimental method: Under sterile conditions, the mother solution was diluted to a concentration of 50 μg / mL with agar medium, and dispensed into a sterile 48-well plate with a pipette and allowed to solidify. The agar medium of the control group contained an equal amount of DMSO. Select sterilized seeds of the same size and sow them on the well plate containing the culture medium, with 24 rapeseed plants or 24 barnyard grass plants for each treatment. The experiment lasted for 7 days. The germination was counted every day from the 1st to the 3rd day. The length of the aboveground and underground parts was measured and photographed on the 7th day. Each group was measured three times and the average value was taken. According to the root length and plant height of the control group and the treatment group, the Δ value (unit: mm) and the inhibition rate (%) were calculated to compare whether the target compound promoted or inhibited the root length and plant height of the plant.
[0145] Δ = root length or plant height of control group - root length or plant height of compound treated group
[0146] The larger the Δ value, the smaller the root length and plant height of the plants treated with the compound are than those of the control group, indicating that the compound has a better inhibitory effect on root length and plant height.
[0147] Inhibition rate = (CK average value - treatment group average value) / (CK average value - 5mm) × 100%
[0148] Table 2. Herbicidal activity Δ values (mm) and inhibition rates (%) of target compounds
[0149]
[0150] Note: Positive values indicate growth inhibition, negative values indicate growth promotion.
[0151] As shown in Table 2, the target compounds have significant inhibitory effects on dicotyledonous plants represented by Portulaca oleracea, especially the inhibition rate of Portulaca oleracea root length is basically above 80%; they have certain inhibitory activity on monocotyledonous plants represented by Echinochloa crusgalli, which is specifically manifested in inhibiting the growth of Echinochloa crusgalli plant height. Compound A19 has an inhibition rate of 50.3% on the plant height of Echinochloa crusgalli, and compounds A7, A9, A11, and A20 have excellent inhibitory activity on the root length and plant height of Portulaca oleracea, with an inhibition rate of 100%, which can be used as potential plant growth regulator molecules to provide references for further structural modification.
[0152] Depend on Figure 1 It can be seen that the purslane blank group was selected as the control, and compounds A4, A5, and A7 showed different inhibitory effects on purslane. Compounds A4 and A5 showed significant inhibitory activity on the root length of purslane, and compound A7 had 100% inhibitory activity on purslane.
[0153] Example 3
[0154] The flavanone phloretin derivatives shown in formula II are synthesized using 4,6-dimethyl-2-hydroxyacetophenone shown in formula VI and substituted or unsubstituted benzaldehyde as raw materials. The synthesis route is as follows:
[0155]
[0156] The specific steps are as follows:
[0157] Dissolve 4,6-dimethyl-2-hydroxyacetophenone (1.8 mmol) and substituted or unsubstituted benzaldehyde (1.0 mmol) in 15 mL of 95% ethanol, add solid NaOH (10 mmol), stir the reaction at room temperature for 2-12 h, monitor the reaction by TLC, quench the reaction with water after completion, add 20 mL of hydrochloric acid (1 M) to the reaction solution, extract with ethyl acetate, combine the organic phases, wash with saturated brine, add anhydrous Na2SO4 to dry, and purify by silica gel column chromatography with PE / EA in a volume ratio of 3:1 to 8:1 as eluent to obtain compound VII.
[0158] Dissolve compound VII (1 mmol) and sodium acetate (10 mmol) in 95% ethanol, heat under reflux for 24-48 hours, monitor the reaction by TLC, and after the reaction is completed, cool the reaction solution to room temperature, pour into ice water, extract with ethyl acetate, combine the organic phases, wash the organic phases with saturated brine, add anhydrous Na2SO4 to dry, and use silica gel column chromatography with PE / EA in a volume ratio of 3:1 to 8:1 as the eluent to purify the target compound II. Dry and weigh. Calculate the yield using 1 H NMR, 13 Its structure was characterized by CNMR, IR and HRMS.
[0159] The obtained flavanone phloretin derivatives are shown in Table 3.
[0160]
[0161] Table 3. Flavanone phloretin derivatives
[0162]
[0163]
[0164] The spectral data of the target compound are as follows:
[0165] C2: 5,7-dimethoxy-2-(o-tolyl)-flavanone
[0166]
[0167] White solid; yield: 60%. mp145.8-147.1℃. 1 H NMR(500MHz,DMSO-d6)δ7.54-7.50(m,1H),7.29-7.22(m,3H),6.22(s,2H),5.69(dd,J=13.0,2.5Hz, 1H), 3.80 (d, J=6.0Hz, 6H), 3.02 (dd, J=16.0, 13.5Hz, 1H), 2.60 (dd, J=16.5, 2.5Hz, 1H), 2.35 (s, 3H). 13 C NMR(125MHz,DMSO-d6)δ188.05,165.46,164.64,161.94,136.93,135.66,130.57,128.40,12 6.20,126.04,105.50,93.75,93.02,75.72,55.97,55.83,18.72(d,J=1.6Hz).HRMS(ESI):m / z calcd for C 18 H 18 O4([M+H] + )299.1278,Found 299.1276.
[0168] C3: 5,7-dimethoxy-2-(o-methoxyphenyl)-flavanone
[0169]
[0170] Pale yellow solid; yield: 55%. mp121.1-122.3℃. 1 H NMR(500MHz,DMSO-d6)δ7.52(dd,J=7.5,1.5Hz,1H),7.40-7.33(m,1H),7.12-7.00(m,2H),6.23(dd,J=10.5,2.0Hz,2H),5.7 0(dd,J=13.0,2.5Hz,1H),3.81(d,J=2.5Hz,6H),3.78(s,2H),2.97(dd,J=16.35,13.0Hz,1H),2.59(dd,J=16.5,3.0Hz,1H). 13C NMR (125MHz, DMSO-d6) δ188.02,165.46,164.62,161.88,155.98,129.69,126.78,120.60,111. 28(d,J=2.2Hz),105.36,93.74,93.00,73.57(d,J=2.0Hz),55.95,55.82,55.68.HRMS(ESI):m / z calcd for C 18 H 18 O5([M+H] + )315.1227,Found 315.1230.
[0171] C4: 5,7-dimethoxy-2-(o-trifluoromethylphenyl)-flavanone
[0172]
[0173] Pale yellow solid; yield: 65%. mp132.6-134.3℃. 1 H NMR (500MHz, DMSO-d6) δ8.02(d,J=8.0Hz,1H),7.82(dd,J=13.5,7.5Hz,2H),7.65(t,J=7.5Hz,1H),6.26(dd,J=9 .5,2.0Hz,2H),5.67(d,J=13.0Hz,1H),3.81(d,J=3.0Hz,6H),3.21(dd,J=16.4,13.5Hz,1H),2.54-2.52(m,1H). 13 C NMR (125MHz, DMSO-d6) δ187.01,165.68,164.18,162.00,137.19,133.29,129.43,128.87,126. 16,125.92,125.33,123.16,105.21,93.82,93.44,74.95,56.06,55.91,45.51.HRMS(ESI):m / z calcd forC 18 H 15 F3O4([M+H] + )353.0995,Found353.0996.
[0174] C5: 5,7-dimethoxy-2-(o-fluorophenyl)-flavanone
[0175]
[0176] White solid; yield: 55%. mp130.1-131.4℃. 1 H NMR(500MHz,DMSO-d6)δ7.66(d,J=8.5Hz),7.43(d,J=8.0Hz),6.24(dd,J=14.5,2.0Hz),5.62( dd,J=12.5,3.0Hz), 3.81(t,J=10.0Hz), 3.05(dd,J=16.5,12.5Hz), 2.69(dt,J=14.0,7.0Hz). 13 C NMR (125MHz, DMSO-d6) δ187.38, 165.56, 164.20, 161.92, 160.69, 158.72, 130.84 (d, J = 8.8Hz), 128.40 (d, J = 4.2Hz), 125. 77(d,J=12.8Hz),124.85(d,J=3.9Hz),115.91,115.74,105.38,93.77,93.22,72.99,56.00,55.87,43.52.HRMS(ESI):m / z calcd for C 17 H 15 FO4([M+H] + )303.1027,Found 303.1026.
[0177] C6: 5,7-dimethoxy-2-(o-chlorophenyl)-flavanone
[0178]
[0179] White solid; yield: 56%. mp148.9-150.7℃. 1 H NMR(500MHz,DMSO-d6)δ7.73(d,J=6.5Hz),7.53(d,J=7.5Hz),7.50-7.40(m),6.25(s),5 .81-5.73(m),3.81(d,J=10.0Hz),3.05(dd,J=16.5,13.0Hz),2.66(dd,J=16.5,2.5Hz). 13 C NMR (125MHz, DMSO-d6) δ187.28,165.59,164.22,161.94,136.14,131.49,130.32,129. 72,128.06,127.82,105.34,93.81,93.28,75.49,56.03,55.90,43.59.HRMS(ESI):m / z calcd for C 17H 15 ClO4([M+H] + )319.0732,Found319.0731.
[0180] C7: 5,7-dimethoxy-2-(o-bromophenyl)-flavanone
[0181]
[0182] White solid; yield: 49%. mp151.2-152.4℃. 1 H NMR (500MHz, DMSO-d6) δ7.71(ddd,J=14.0,8.0,1.5Hz),7.51(td,J=7.5,1.0Hz),7.36(td,J=8.0,1.5Hz),6.26( q, J=2.5Hz), 5.69 (dd, J=13.0, 2.5Hz), 3.82 (t, J=9.0Hz), 3.03 (dd, J=16.5, 13.0Hz), 2.67 (dd, J=16.5, 3.0Hz). 13 C NMR (125MHz, DMSO-d6) δ187.23,165.61,164.21,161.95,137.66,132.95,130.63,128. 37,128.24,121.72,105.33,93.83,93.30,77.78,56.04,55.90,43.72.HRMS(ESI):m / z calcd for C 17 H 15 BrO4([M+H] + )363.0226,Found 363.0221.
[0183] C8: 5,7-dimethoxy-2-(m-tolyl)-flavanone
[0184]
[0185] White solid; yield: 55%. mp146.2-147.5℃. 1H NMR (500MHz, DMSO-d6) δ7.37-7.26(m,1H),7.18(d,J=6.0Hz,1H),6.22(dd,J=14.0,2.0Hz,1H),5.49(dd,J=12. 5,3.0Hz,0H),3.79(d,J=13.5Hz,2H),3.03(dd,J=16.5,13.0Hz,1H),2.62(dd,J=16.5,3.0Hz,1H),2.33(s,1H). 13 C NMR (125MHz, DMSO-d6) δ187.87,165.52,164.39,161.87,139.04,137.85,129.15,128.53,127.1 6,123.69,105.48,93.81,93.02,78.45,55.98,55.86,44.95(d,J=1.3Hz),21.17.HRMS(ESI):m / z calcd for C 18 H 18 O4([M+H] + )299.1278,Found299.1277.
[0186] C9): 5,7-dimethoxy-2-(m-methoxyphenyl)-flavanone
[0187]
[0188] Pale yellow solid; yield: 63%. mp103.7-105.3℃. 1 H NMR (500MHz, DMSO-d6) δ7.33(t,J=8.0Hz),7.07(d,J=6.5Hz),6.93(d,J=9.0Hz),6.32-6.17( m), 5.51 (d, J = 12.5Hz), 3.91-3.69 (m), 3.04 (dd, J = 16.0, 13.0Hz), 2.65 (dd, J = 16.5, 2.5Hz). 13 C NMR(125MHz,DMSO-d6)δ187.78,165.51,164.30,161.86,159.46,140.70,129.76,118.64, 113.88,112.23,105.49,93.82,93.01,78.30,55.95,55.84,55.24,44.92.HRMS(ESI):m / z calcdfor C 18 H 18 O5([M+H] +)315.1227,Found 315.1223.
[0189] C10: 5,7-Dimethoxy-2-(trifluoromethylphenyl)-flavanone
[0190]
[0191] White solid; yield: 47%. mp117.6-119.3℃. 1 H NMR(500MHz,DMSO-d6)δ7.66(d,J=8.5Hz),7.43(d,J=8.0Hz),6.24(dd,J=14.5,2.0Hz),5.62( dd,J=12.5,3.0Hz), 3.81(t,J=10.0Hz), 3.05(dd,J=16.5,12.5Hz), 2.69(dt,J=14.0,7.0Hz). 13 C NMR(125MHz,DMSO-d6)δ187.43,165.59,164.13,161.90,140.61,130.66,129.81,129.57,129.32,1 25.21,123.33-123.07(m),105.47,93.86,93.22,77.69,55.96,55.86,44.79.HRMS(ESI):m / zcalcd for C 18 H 15 F3O4([M+H] + )353.0995,Found 353.0999.
[0192] C11: 5,7-dimethoxy-2-(m-fluorophenyl)-flavanone
[0193]
[0194] Pale yellow solid; yield: 63%. mp157.4-158.7℃. 1 H NMR (500MHz, DMSO-d6) δ7.71(ddd,J=14.0,8.0,1.5Hz),7.51(td,J=7.5,1.0Hz),7.36(td,J=8.0,1.5Hz),6.26( q, J=2.5Hz), 5.69 (dd, J=13.0, 2.5Hz), 3.82 (t, J=9.0Hz), 3.03 (dd, J=16.5, 13.0Hz), 2.67 (dd, J=16.5, 3.0Hz). 13C NMR (125MHz, DMSO-d6) δ187.55, 165.58, 164.13, 163.27, 161.89, 161.33, 141.97 (d, J = 7.9Hz), 130.75 (d, J = 9.2Hz), 122.63 (d, J = 3. 6Hz), 115.38 (d, J = 1.2Hz), 115.22 (d, J = 1.2Hz), 113.53, 113.35, 105.48, 93.88, 93.15, 77.61, 56.00, 55.89, 44.71. HRMS (ESI): m / z calcd for C 17 H 15 FO4([M+H] + )303.1027,Found 303.1026.
[0195] C12: 5,7-dimethoxy-2-(m-chlorophenyl)-flavanone
[0196]
[0197] White solid; yield: 66%. mp148.8-150.4℃. 1 H NMR(500MHz,DMSO-d6)δ7.73(d,J=6.5Hz),7.53(d,J=7.5Hz),7.50-7.40(m),6.25(s), 5.81-5.73(m),3.81(d,J=10.0Hz),3.05(dd,J=16.5,13.0Hz),2.66(dd,J=165,2.5Hz). 13 C NMR (125MHz, DMSO-d6) δ187.49,165.56,164.11,161.86,141.60,133.34,130.60,128. 44,126.45,125.22,105.45,93.85,93.16,77.57,55.99,55.89,44.69.HRMS(ESI):m / z calcd for C 17 H 15 ClO4([M+H] + )319.0732,Found319.0732.
[0198] C13: 5,7-dimethoxy-2-(m-bromophenyl)-flavanone
[0199]
[0200] Pale yellow solid; yield: 38%. mp125.8-127.3℃. 1 H NMR (500MHz, DMSO-d6) δ7.75(s,1H),7.55(dd,J=26.0,8.0Hz,2H),7.39(t,J=8.0Hz,1H),6.25(dd,J=28.0,2.0Hz,3H ),5.57(dd,J=12.5,2.5Hz,1H),3.80(d,J=15.5Hz,6H),3.05(dd,J=16.5,13.0Hz,1H),2.68(dd,J=16.5,3.0Hz,1H). 13 C NMR (125MHz, DMSO-d6) δ187.43,165.52,164.07,161.83,141.79,131.32,130.83,129. 28,125.57,121.89,105.43,93.83,93.14,77.50,55.96,55.86,44.68.HRMS(ESI):m / z calcd for C 17 H 15 BrO4([M+H] + )363.0226,Found 363.0223.
[0201] C14: 5,7-dimethoxy-2-(p-tolyl)-flavanone
[0202]
[0203] White solid; yield: 34%. mp163.8-165.4℃. 1 H NMR(500MHz,DMSO-d6)δ7.39(d,J=8.0Hz),7.22(d,J=7.5Hz),6.21(dd,J=10.0,2.0Hz), 5.58-5.39(m),3.79(d,J=13.5Hz),3.02(dt,J=30.0,15.0Hz),2.69-2.54(m),2.32(s). 13 C NMR(125MHz,DMSO-d6)δ187.93,165.50,164.39,161.87,137.86,136.14,129.16, 126.62,105.50,93.80,92.98,78.31,55.97,55.85,44.87,20.90.HRMS(ESI):m / z calcd for C 18 H 18 O4([M+H]+ )299.1278,Found 299.1275.
[0204] C15: 5,7-dimethoxy-2-(p-methoxyphenyl)-flavanone
[0205]
[0206] Pale yellow solid; yield: 48%. mp136.5-138.2℃. 1 H NMR (500MHz, DMSO-d6) δ7.47 (d, J = 8.0Hz), 7.00 (d, J = 8.5Hz), 6.23 (d, J = 4.5Hz), 5.48 (d, J = 12.5Hz), 3.94-3.70 (m), 3.23-2.94 (m), 2.62 (d, J = 16.5Hz). 13 C NMR(125MHz,DMSO-d6)δ188.12,165.51,164.50,161.92,159.50,131.06,128.23, 113.96,105.50,93.78,92.92,78.26,55.92,55.79,55.25,44.86.HRMS(ESI):m / z calcd for C 18 H 18 O5([M+H] + )315.1227,Found 315.1225.
[0207] C16: 5,7-Dimethoxy-2-(p-trifluoromethylphenyl)-flavanone
[0208]
[0209] White solid; yield: 62%. mp141.5-142.6℃. 1 H NMR(500MHz,DMSO-d6)δ7.78(dd,J=26.5,8.2Hz,1H),6.29-6.22(m,1H),5.69(dd,J=12.5,2. 5Hz,1H),3.81(d,J=16.5Hz,1H),3.02(dd,J=16.5,12.5Hz,1H),2.74(dd,J=16.5,3.0Hz,1H). 13C NMR(125MHz,DMSO-d6)δ187.27,165.58,164.01,161.89,143.77(d,J=1.5Hz),129.05,128.79,127.20, 125.56(q,J=4.3Hz),125.34,123.17,105.50,93.86,93.18,77.56,55.98,55.86,44.73.HRMS(ESI):m / z calcd for C 18 H 15 F3O4([M+H] + )353.0995,Found 353.0994.
[0210] C17: 5,7-dimethoxy-2-(p-fluorophenyl)-flavanone
[0211]
[0212] White solid; yield: 58%. mp160.2-161.5℃. 1 H NMR(500MHz,DMSO-d6)δ7.48-7.41(m),6.21(dd,J=5.5,2.5Hz),5.50(dd,J=12.5,3.0Hz),3 .79(d,J=12.5Hz), 3.05(dd,J=16.5,12.5Hz), 2.65(dd,J=16.5,3.0Hz), 1.29(d,J=4.5Hz). 13 C NMR (125MHz, DMSO-d6) δ187.76,165.54,164.28,163.11,161.90,161.17,135.37,128.91(d,J=8 .5Hz),115.46(d,J=21.5Hz),105.47,93.82,93.07,77.78,55.98,55.85,44.84.HRMS(ESI):m / z calcdfor C 17 H 15 FO4([M+H] + )303.1027,Found 303.1025.
[0213] C18: 5,7-dimethoxy-2-(p-chlorophenyl)-flavanone
[0214]
[0215] White solid; yield: 56%. mp169.5-171.0℃. 1H NMR (500MHz, DMSO-d6) δ7.47 (d, J = 8.0Hz), 7.00 (d, J = 8.5Hz), 6.23 (d, J = 4.5Hz), 5.48 (d, J = 12.5Hz), 3.94-3.70 (m), 3.23-2.94 (m), 2.62 (d, J = 16.5Hz). 13 C NMR (125MHz, DMSO-d6) δ187.57,165.55,164.16,161.89,138.12,133.10,128. 65,128.49,105.48,93.84,93.10,77.64,55.98,55.86,44.75.HRMS(ESI):m / z calcd for C 17 H 15 ClO4([M+H] + )319.0732,Found 319.0730.
[0216] C19: 5,7-dimethoxy-2-(p-bromophenyl)-flavanone
[0217]
[0218] Pale yellow solid; yield: 52%. mp168.7-170.3℃. 1 H NMR(500MHz,DMSO-d6)δ7.63(d,J=8.0Hz),7.48(d,J=8.0Hz),6.29-6.18(m),5.62- 5.50 (m), 3.80 (d, J = 15.0Hz), 3.03 (dt, J = 16.0, 15.0Hz), 2.65 (dt, J = 21.0, 10.5Hz). 13 C NMR (125MHz, DMSO-d6) δ187.51,165.52,164.13,161.86,138.53,131.56,128. 77,121.66,105.46,93.82,93.10,77.66,55.97,55.85,44.71.HRMS(ESI):m / z calcd for C 17 H 15 BrO4([M+H] + )363.0226,Found363.0219.
[0219] Example 4
[0220] Evaluation of the Herbicidal Activity of Flavanone Phloretin Derivatives
[0221] Seed germination experiments were conducted on the target compounds, with dicotyledonous plants (Purslane) and monocotyledonous plants (Echinochloa crusgalli) as experimental subjects.
[0222] Experimental equipment: high pressure sterilizer, pipette, electric constant temperature biochemical incubator, double-sided clean workbench for two people, 5mm puncher, inoculation ring, alcohol lamp, culture dish, etc.
[0223] Experimental material preparation: The target compound was dissolved in DMSO to prepare a stock solution with a concentration of 50000 μg / mL. Agar (Merck, USA) was weighed on a balance and dissolved in double distilled water to prepare an agar medium with a mass fraction of about 2.0%, and then sterilized with high temperature and high pressure.
[0224] Experimental method: Under sterile conditions, the mother solution was diluted to a concentration of 50 μg / mL with agar medium, and dispensed into a sterile 48-well plate with a pipette and allowed to solidify. The agar medium of the control group contained an equal amount of DMSO. Select sterilized seeds of the same size and sow them on the well plate containing the culture medium, with 24 rapeseed plants or 24 barnyard grass plants for each treatment. The experiment lasted for 7 days. The germination was counted every day from the 1st to the 3rd day. The length of the aboveground and underground parts was measured and photographed on the 7th day. Each group was measured three times and the average value was taken. According to the root length and plant height of the control group and the treatment group, the Δ value (unit: mm) and the inhibition rate (%) were calculated to compare whether the target compound promoted or inhibited the root length and plant height of the plant.
[0225] Δ = root length or plant height of control group - root length or plant height of compound treated group
[0226] The larger the Δ value, the smaller the root length and plant height of the plants treated with the compound are than those of the control group, indicating that the compound has a better inhibitory effect on root length and plant height.
[0227] Inhibition rate = (CK average value - treatment group average value) / (CK average value - 5mm) × 100%
[0228] Table 4. Herbicidal activity Δ values (mm) and inhibition rates (%) of target compounds
[0229]
[0230] Note: Positive values indicate growth inhibition, negative values indicate growth promotion.
[0231] As shown in Table 4, the inhibitory activity of the flavanone phloretin derivatives on purslane is better than that on barnyard grass, especially on the root length and plant height of purslane, and has a certain inhibitory activity on the plant height of barnyard grass, and has a significant growth-promoting effect on the root length of barnyard grass. Compounds C3, C9, C15 and C18 have excellent inhibitory activity on the root length of purslane, and the inhibition rate is higher than 90%. Compounds C3 and C4 can significantly inhibit the root length and plant height growth of purslane at the same time ( Figure 2 ), the inhibition rates of root length were 74.8% and 72.9% respectively. The introduction of -OCH3 group can significantly enhance the inhibitory activity against the dicotyledonous plant Portulaca oleracea, especially when -OCH3 is introduced at the ortho position (compound C3), which exhibits the best inhibitory effect on Portulaca oleracea.
Claims
1. Phloretin derivatives or physiologically compatible salts thereof having structures as shown in Formula I and Formula II: in, R 1 Selected from H, F, Cl, Br, C 1 -C 3 Alkyl, OH, C 1 -C 3 Alkoxy or halogen substituted C 1 -C 3 Alkyl, but not including R 1 is selected from Cl substituted at the 4' position; R 2 Selected from F, Cl, Br, C 1 -C 3 Alkyl, C 1 -C 3 Alkoxy, halogen substituted C 1 -C 3 Alkyl, but not including R 2 Selected from OCH substituted at the 2' position 3 , Cl, Br, 3' substituted CH 3 、OCH 3 , Cl, Br, 4' substituted CH 3 、OCH 3 CF 3 , F, Cl, Br.
2. The phloretin derivative or a physiologically compatible salt thereof according to claim 1, Features: R 1 Selected from H, F, Cl, Br, CH 3 , OH, OCH 3 or CF 3 , but does not include OH substituted at the 2' position and Cl substituted at the 4' position; R 2 Selected from 2'-substituted F, CH 3 or CF 3 , F or CF substituted at the 3' position 3 .
3. The phloretin derivative or a physiologically compatible salt thereof according to claim 2, Features: R 1 Selected from H, 2'-substituted F, Cl, Br, CH 3 、OCH 3 or CF 3 , 3'-substituted F, Cl, Br, CH 3 、OCH 3 or CF 3 , 4' substituted F, CH 3 、OCH 3 or CF 3 ; R 2 Selected from F or CF substituted at the 2' position 3 , F or CF substituted at the 3' position 3 .
4. The phloretin derivative or a physiologically compatible salt thereof according to claim 3, Features: R 1 Selected from H, 2'-substituted F, Cl or OCH 3 , Cl, CH substituted at the 3' position 3 、OCH 3 or CF 3 , 4' substituted F or CH 3 .
5. A phloretin derivative or a physiologically compatible salt thereof having a structure as shown in Formula I: in, R 1 Selected from Cl substituted at 2', CH substituted at 3' 3 or OCH 3 , F substituted at the 4' position.
6. A method for preparing the phloretin derivative according to claim 1, Features: The synthetic route of phloretin derivatives containing amide structure is as follows: The synthetic route of flavanone phloretin derivatives is as follows:
7. Use of the phloretin derivative or a physiologically compatible salt thereof according to any one of claims 1 to 5 in plant growth regulation or weed control, wherein the plant growth regulation is to inhibit the root length and plant height of the plant.
8. A plant growth regulator or herbicide, Features: The invention uses the phloretin derivative or its physiologically compatible salt as claimed in any one of claims 1 to 5 as an effective component or a main effective component.
9. Application of phloretin derivatives with structures as shown in Formula I and Formula II or their physiologically compatible salts in plant growth regulation or weed control: in, R 1 is selected from Cl substituted at the 4' position; R 2 Selected from OCH substituted at the 2' position 3 , Cl, Br, 3' substituted CH 3 、OCH 3 , Cl, Br, 4' substituted CH 3 、OCH 3 CF 3 , F, Cl, Br; Preferably, R 1 is selected from Cl substituted at the 4' position; R 2 Selected from OCH substituted at the 2' position 3 , Cl, 3' substituted CH 3 、OCH 3 , Br, 4'-substituted OCH 3 , F, Cl.
10. The use according to claim 7 or 9, Features: The application is application in preventing and controlling dicotyledonous weeds and monocotyledonous weeds.
